Skip to main content
Caplight Logo









Valo Health

Valo Health

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://valohealth.com

Last Round

Strategic

Jan 8, 2025

Est. Valuation

$2.8B

Total Funding Raised

$560M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Valo Health operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Strategic round in January 2025.

Valo Health is a biotechnology company that leverages human-centric data and artificial intelligence through its Opal Computational Platform to streamline and accelerate the drug discovery and development process.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Valo Health Comparables

Compare Valo Health with similar companies based on industry and business-model similarity.

Valo Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insitro
90%
Insilico Medicine
87%
Iambic Therapeutics
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Valo Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 8, 2025
Series COct 28, 2022
M&ANov 15, 2021
SPAC Merger / PIPEJun 9, 2021
Series BMar 9, 2021
Series B
Jan 11, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Brian Alexander

Chief Executive Officer

Executive Team

Guido Lanza

SVP and CTO

Executive Team

Brett Blackman

Chief Operating Officer, Chief Innovation Officer, Head of Corporate Business Development

Executive Team

For institutional investors. Book with your work email.

Valo Health Investors

Notable investors and investment history

Valo Health investors
InvestorRounds
Hercules CapitalDebt
Global Founders CapitalSeries C
Khosla VenturesSPAC Merger / PIPE, M&A, Series B
MissionBlue Capital PartnersSeries B
Longevity Vision FundSPAC Merger / PIPE, Series C, M&A
Public Sector Pension Investment BoardSPAC Merger / PIPE, Series A, M&A, Series B
CAZ InvestmentsSPAC Merger / PIPE, M&A
Book a demo to see all 23 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2026

    Valo Health and Montai Therapeutics merged to form a drug discovery platform.

  • Feb 3, 2026

    Karin Conde-Knape appointed as the new Chief Scientific Officer.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • merges_withNov 11, 2026

    On Nov 11th '26 in Massachusetts, Valo Health and Montai Therapeutics, Inc. announce a merger that forms a leading drug discovery platform and retains Valo Health's name.

Book a demo to see all news

For institutional investors. Book with your work email.

Valo Health Filings

Explore SEC and related filing metadata, where available.

Valo Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Valo Health's valuation, stock price, and market status.

Is Valo Health a public or private company?

Valo Health is a private company.

What is the current stock price of Valo Health?

Valo Health is a private company, so its shares have no public market price. Caplight tracks Valo Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Valo Health worth (valuation)?

Valo Health's valuation is estimated at $2.8B based on funding round data.

Can I buy Valo Health stock?

Valo Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Valo Health's last funding round?

Valo Health's most recent funding round was Strategic on January 8, 2025.

Who are the main investors in Valo Health?

Key investors in Valo Health include Hercules Capital, Public Sector Pension Investment Board, Koch Disruptive Technologies, Flagship Pioneering, Koch Disruptive Technologies.

Will Valo Health IPO soon?

No public IPO plans have been announced for Valo Health.

How can I track Valo Health secondary market activity?

Caplight tracks bids, offers, and trades in Valo Health's shares on secondary markets.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range163
Year Founded2019
Last FundingJan 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?